Pre-exposure Option for Reducing HIV in the UK: an Open-label Randomisation to Immediate or Deferred Daily Truvada for HIV Negative Gay Men.(PROUD)
Phase of Trial: Phase IV
Latest Information Update: 11 Jun 2019
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- Acronyms PROUD
- 26 Jul 2017 Long term follow up results, presented at the 9th International AIDS Society Conference on HIV Science.
- 04 Jan 2017 Status changed from active, no longer recruiting to completed.
- 06 Sep 2014 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical research Network record.